This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for ...

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion to treat CIDP in Canada TORONTO, March 27, 2025 /CNW/ - Takeda Canada Inc. (Takeda) is pleased ...

Beta-trace protein (BTP) may have potential uses as a novel biomarker for chronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barré syndrome (GBS), according to a study published in ...

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground. But when he failed to get up and told ...

Competing interests BCJ receives research support from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Spierfonds, Stichting Spieren voor Spieren, ...

Research on peripheral neuropathies, especially GBS, CIDP, or CMT is receiving increased attention, contributing to the evolving landscape of neurological regeneration. The ENS, part of the autonomic ...

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.

Following a decline in GBS cases, PMC has written to the state public health department on Thursday to declare end of the rare nerve disorder outbreak Pune: Following a decline in Guillain-Barré ...